Zymeworks (ZYME) Cash from Investing Activities (2021 - 2026)

Zymeworks (ZYME) has 6 years of Cash from Investing Activities data on file, last reported at $70.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 474.28% year-over-year to $70.0 million; the trailing twelve-month figure through Mar 2026 stood at $84.4 million (up 44.95% YoY), and the FY2025 full-year result was $26.7 million, down 31.2% from the prior year.
• Cash from Investing Activities grew to $70.0 million in Q1 2026, from $5.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $72.3 million in Q3 2024 to a low of -$138.2 million in Q1 2023.
• A 5-year average of -$7.4 million and a median of -$6.2 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities sank 1088.21% in 2022 and soared 1129.3% in 2024, its largest moves.
• Tracing ZYME's Cash from Investing Activities over 5 years: stood at -$22.1 million in 2022, then surged by 93.94% to -$1.3 million in 2023, then tumbled by 364.77% to -$6.2 million in 2024, then jumped by 186.39% to $5.4 million in 2025, then soared by 1203.26% to $70.0 million in 2026.
• Business Quant data shows ZYME's Cash from Investing Activities at $70.0 million in Q1 2026, $5.4 million in Q4 2025, and $368000.0 in Q3 2025.